decisionhealth Newsletters, Part B News - 2005 Issue 5 (May)
Correct Coding Initiative: Expect elimination of controversial infusion code edit
Subscribe or sign in to view the full article.
Article Overview
This premium article explains a change in National Correct Coding Initiative guidance affecting chemotherapy and infusion-related G codes, including a temporary billing workaround before an updated version is released. It is relevant to oncology coders, billing staff, and compliance professionals who follow Medicare Part B payment edits, modifier usage, and audit risk. The article also discusses timing of the update, the affected code groupings, and administrative guidance from the contractor maintaining the edit set.
Why This Topic Matters
Coding staff working in oncology and infusion services need to know when an edit is being reversed, what period it applies to, and how claims may be handled before and after the update. The article also highlights compliance and audit considerations tied to modifier use.
Article Sections
-
Edit reversal and temporary claims handling
Explains that a previously reported National Correct Coding Initiative edit is being reversed and describes the interim handling of claims until the updated version becomes effective.
-
Codes affected by the update
Summarizes the oncology-related G code groupings referenced in the article and the broader categories of infusion and chemotherapy services involved.
-
Compliance concerns and audit risk
Discusses concerns raised by oncology experts about modifier use, claim processing, and the possibility of audit scrutiny.
-
Practical tip for keeping documentation
Provides a general reminder about retaining prior edit information for administrative support and audit preparedness.
What You Will Learn
- How the article frames a correction to a National Correct Coding Initiative edit
- Which general types of oncology infusion services are implicated in the update
- What timing considerations are mentioned for claim processing and edit implementation
- Why the article raises compliance and audit concerns related to modifier use
- What documentation-related advice is discussed for retaining prior edit information
Who Should Read This
- Oncology coders
- Medical billing staff
- Compliance professionals
- Practice managers
- Revenue cycle personnel
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com